← Leaderboards
James Thomas
University Of Wisconsin Madison
$18,608
Attributed
$18,608
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$18,608 · 2
By mechanism
M01$18,608 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin Madison
Same institution · by research overlap
- Yousif H Matloub$547,398
- Barbara A Blodi$5,082,053
- George Wilding$32,976,854
- William Franklin Dove$12,247,712
- Alan C Rapraeger$12,873,938
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchLeucovorinNeoplasm /Cancer ChemotherapyPatient Oriented ResearchHuman SubjectHuman Therapy EvaluationFluorouracilIrinotecanKinase InhibitorPharmacokineticsThalidomideAntineoplasticsTherapy Adverse EffectClinical Trial Phase IiiColorectal NeoplasmsCombination ChemotherapyDiarrheaDrug Screening /EvaluationGastrointestinal Disorder Chemotherapy
Grant awards (3)
FIRST-LINE CHEMOTHERAPY WITH OXALIPLATIN/5-FU/LV AND PTK787/ZK 222584 OR PLACEBO$9,363
M01 · FY2005 · RR
First-Line Chemotherapy with Oxaliplatin/5-FU/LV and PTK787/ZK 222584 or Placebo$8,089
M01 · FY2004 · RR
Phase II Thalidomide for Prevention of Diarrhea Associated with CPT-11/5-FU/LV$1,156
M01 · FY2004 · RR